참고문헌
- Bailey, A. L. and Sullivan, S. M., Efficient encapsulation of DNA plasmids in small neutral liposomes induced by ethanol and calcium. Biochim. Biophys. Acta, 1468, 239-252 (2000) https://doi.org/10.1016/S0005-2736(00)00264-9
- Boris-Lawrie, K. A. and Temin, H. M., Recent advances in retrovirus vectortechnology. Curr. Opin. Genet. Dev., 3, 102-109 (1993) https://doi.org/10.1016/S0959-437X(05)80349-1
- Harrison, G. S.,Wang, Y., Tomezak, J., Hogan, C., Shpall, E. J., Curiel, T. J., and Feigner, P. L., Optimization of genetransfer using cationic lipids in cell lines and primary human CD4+ and CD34 hematopoietic cells. Biotechniques, 19, 816-823 (1995)
- Huwyler, J., Dafang, W., and Pardridge, W. M., Brain drug delivery of small molecules using immunoliposomes. Proc. Natl. Acad. Sci. U.S.A., 93,14164-14169 (1996) https://doi.org/10.1073/pnas.93.24.14164
- Lamb, B. T., Sisodia, S. S., Lawler, A. M., Siunt, H. H., Kitt, C. A., Kearns, W. G., Pearson, P. L., Price, D. L., and Gearhart, J. D., Introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic mice. Nature Genet., 5, 22-30 (1993) https://doi.org/10.1038/ng0993-22
- Li, S. and Huang, L., In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther., 4, 891-900 (1997) https://doi.org/10.1038/sj.gt.3300482
- Li, S. and Huang, L., Nonviral gene therapy: promises and challenges. GeneTher., 7, 31-34 (2000) https://doi.org/10.1038/sj.gt.3301110
- Mamot, C., Drummond, D. C., Greiser, U., Hong, K., Kirpotin, D. B., Marks, J. D., and Park, J. W., Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediated specific and efficient drug delivery to EGFR- and EGFRvllloverexpressing tumor cells. Cancer Res., 63, 3154-3161 (2003)
- Maruyama, K., Ishida, O., Takizawa, T., and Moribe, K., Possibility of active targeting to tumor tissues with liposomes. Adv. Drug Deliv. Rev., 40, 89-102 (1999) https://doi.org/10.1016/S0169-409X(99)00042-3
- Miller, A. D., Retroviral vectors. Curr. Top. Microbiol. Immunol., 158, 1-24 (1992) https://doi.org/10.1007/978-3-642-75608-5_1
- Monnard, P.-A., Oberholzer,T., and Luisi, P. L., Entrapment of nucleic acids in liposomes. Biochim. Biophys. Acta,1329, 3950 (1997)
- Nabel, G. J., Nabel, E. G., Yang, Z.-Y., Fox, B. A., Plautz, G. E., Gao, X., Huang, L., Shu, S., Gordon, D., and Chang, A. E., Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity and lack of toxicity in humans. Proc. Natl. Acad. Sci. U.S.A., 90, 11307-11311 (1993) https://doi.org/10.1073/pnas.90.23.11307
- Pardridge, W. M., Buciak, J. L., and Yoshikawa, T., Transport of recombinant CD4 through the rat blood-brain barrier in vivo. J. Pharmacol. Exp. Ther., 261, 1175-1180 (1992)
- Park, H. M., Chung, S. Y., Go, E. J., and Lee, H. J., Preparation and characterization of plasmid DNA encapsulated in liposomes. J. Kor. Pharm. Sci., 33, 209-213 (2003)
- Pastorino, F., Stuart, D., Ponzoni, M., and Allen, T. M., Targeted delivery of antisense oligonucleotides in cancer. J. Control Release, 74, 69-75 (2001) https://doi.org/10.1016/S0168-3659(01)00312-1
- Saravolac, E. G., Ludkovski,O., Skirrow, R., Ossanlou, M., Zhang, Y. P., Giesbrecht, C., Thompson, J., Thomas, S., Stark, H., Cullis, P. R., and Scherrer, P., Encapsulation of plasmid DNA in stabilized plasmid-lipid particles composed of different cationic lipid concentration for optimal transfection activity. J. Drug Target, 7, 423-437 (2000) https://doi.org/10.3109/10611860009102217
- Schatzlein, A. G., Non-viral vectors in cancer gene therapy: principles and progress. Anti-Cancer Drugs, 12, 275-304 (2001) https://doi.org/10.1097/00001813-200104000-00001
- Setoguchi, Y., Jaffe, H. A., Chu, C.-S., and Crystal, R. G., Intraperitoneal in vivo gene therapy to deliver alpha 1antitrypsin to the systemic circulation. Am. J. Resp. Cell. Mol. BioI., 10, 369-377 (1994) https://doi.org/10.1165/ajrcmb.10.4.8136153
- Shi, N. and Pardridge, W. M., Noninvasive gene targeting to the brain. Proc. Natl. Acad. Sci. U.S.A., 97, 7567-7572 (2000) https://doi.org/10.1073/pnas.130187497
- Smith, T. A., Mehaffey, M. G., Kayda, D. B., Saunders, J. M., Yei, S., Trapnell, B. C., McClelland, A., and Kaleko, M., Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nature Genet., 5, 397-402 (1993) https://doi.org/10.1038/ng1293-397
- Stuart, D. D. and Allen, T. M., A new liposomal formulation for antisense oligodeoxynucleotides with small size, high incorporation efficiency and good stability. Biochim. Biophys. Acta,1463, 219-229 (2000) https://doi.org/10.1016/S0005-2736(99)00209-6
- Worgall, S., Wolff, G., Falck-Pedersen, E., and Crystal, R. G., Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum. Gene Ther., 8, 37-44 (1997) https://doi.org/10.1089/hum.1997.8.1-37
- Yang, Y., Li, Q., Ertl, H. C., and Wilson, J. M., Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol., 69, 2004-2015 (1995a)
- Yang, Y., Nunes, F. A., Berencsi, K., Furth, E. E., Gonczol, E., and Wilson, J. M., Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. U. S. A., 91, 4470-4411 (1995b)